"The new rules would prevent medical professionals with financial conflicts greater than $50,000 from advising the agency no matter the need for their expertise. And only those free of all potential conflicts would be allowed to fully participate and vote on sensitive decisions such as drug or medical device approval. The rules will be open for public comment during the next 60 days."